Last Posted: Jan 25, 2019
- A Mendelian Randomization Approach for Assessing the Relationship Between Physical Activity and Depression.
Chekroud Adam Mourad et al. JAMA psychiatry 2019 Jan - Assessment of Bidirectional Relationships Between Physical Activity and Depression Among Adults: A 2-Sample Mendelian Randomization Study.
Choi Karmel W et al. JAMA psychiatry 2019 Jan - An economic model of the cost-utility of pre-emptive genetic testing to support pharmacotherapy in patients with major depression in primary care.
Sluiter Reinier L et al. The pharmacogenomics journal 2019 Jan - Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
McCuaig Jeanna M et al. Gynecologic oncology 2019 Jan - Genetic associations with suicide attempt severity and genetic overlap with major depression.
Levey Daniel F et al. Translational psychiatry 2019 Jan (1) 22 - A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases.
Oliveri Serena et al. Frontiers in genetics 2018 9624 - Huge trove of British biodata is unlocking secrets of depression, sexual orientation, and more
J Kaiser et al, Science, January 3, 2019 - Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?
Solomon Haley V et al. Psychiatry research 2018 Dec 271604-613 - Polygenic risk score identifies associations between sleep duration and diseases determined from an electronic medical record biobank.
Dashti Hassan S et al. Sleep 2018 Dec - Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
Bousman Chad A et al. Pharmacogenomics 2019 Jan 20(1) 37-47
.png)
No hay comentarios:
Publicar un comentario